BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32206244)

  • 1. Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among
    Kovalenko OP; Volynets GP; Rybak MY; Starosyla SA; Gudzera OI; Lukashov SS; Bdzhola VG; Yarmoluk SM; Boshoff HI; Tukalo MA
    Medchemcomm; 2019 Dec; 10(12):2161-2169. PubMed ID: 32206244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases.
    Rybak MY; Balanda AO; Yatsyshyna AP; Kotey IM; Starosyla SA; Bdzhola VG; Lukash LL; Yarmoluk SM; Tukalo MA; Volynets GP
    Sci Rep; 2021 Mar; 11(1):7162. PubMed ID: 33785838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeted hit identification using pharmacophore screening.
    Volynets GP; Starosyla SA; Rybak MY; Bdzhola VG; Kovalenko OP; Vdovin VS; Yarmoluk SM; Tukalo MA
    J Comput Aided Mol Des; 2019 Nov; 33(11):955-964. PubMed ID: 31691918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of dual-targeted
    Volynets GP; Usenko MO; Gudzera OI; Starosyla SA; Balanda AO; Syniugin AR; Gorbatiuk OB; Prykhod'ko AO; Bdzhola VG; Yarmoluk SM; Tukalo MA
    Future Med Chem; 2022 Sep; 14(17):1223-1237. PubMed ID: 35876255
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery of potent anti-tuberculosis agents targeting leucyl-tRNA synthetase.
    Gudzera OI; Golub AG; Bdzhola VG; Volynets GP; Lukashov SS; Kovalenko OP; Kriklivyi IA; Yaremchuk AD; Starosyla SA; Yarmoluk SM; Tukalo MA
    Bioorg Med Chem; 2016 Mar; 24(5):1023-31. PubMed ID: 26822568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review.
    Bouz G; Zitko J
    Bioorg Chem; 2021 May; 110():104806. PubMed ID: 33799176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.
    Palencia A; Li X; Bu W; Choi W; Ding CZ; Easom EE; Feng L; Hernandez V; Houston P; Liu L; Meewan M; Mohan M; Rock FL; Sexton H; Zhang S; Zhou Y; Wan B; Wang Y; Franzblau SG; Woolhiser L; Gruppo V; Lenaerts AJ; O'Malley T; Parish T; Cooper CB; Waters MG; Ma Z; Ioerger TR; Sacchettini JC; Rullas J; Angulo-Barturen I; Pérez-Herrán E; Mendoza A; Barros D; Cusack S; Plattner JJ; Alley MR
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6271-80. PubMed ID: 27503647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of pyrimidine substituted aminoacyl-sulfamoyl nucleosides as potential inhibitors targeting class I aminoacyl-tRNA synthetases.
    Nautiyal M; De Graef S; Pang L; Gadakh B; Strelkov SV; Weeks SD; Van Aerschot A
    Eur J Med Chem; 2019 Jul; 173():154-166. PubMed ID: 30995568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A consequence of drug targeting of aminoacyl-tRNA synthetases in Mycobacteriumtuberculosis.
    Ndagi U; Kumalo HM; Mhlongo NN
    Chem Biol Drug Des; 2021 Sep; 98(3):421-434. PubMed ID: 33993612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A continuous assay for monitoring the synthetic and proofreading activities of multiple aminoacyl-tRNA synthetases for high-throughput drug discovery.
    Grube CD; Roy H
    RNA Biol; 2018; 15(4-5):659-666. PubMed ID: 29168435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid phenylthiazole and 1,3,5-triazine target cytosolic leucyl-tRNA synthetase for antifungal action as revealed by molecular docking studies.
    Singh UP; Bhat HR; Gahtori P; Singh RK
    In Silico Pharmacol; 2013; 1():3. PubMed ID: 25505648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656).
    Li X; Hernandez V; Rock FL; Choi W; Mak YSL; Mohan M; Mao W; Zhou Y; Easom EE; Plattner JJ; Zou W; Pérez-Herrán E; Giordano I; Mendoza-Losana A; Alemparte C; Rullas J; Angulo-Barturen I; Crouch S; Ortega F; Barros D; Alley MRK
    J Med Chem; 2017 Oct; 60(19):8011-8026. PubMed ID: 28953378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design of Hit Compounds Targeting
    Rybak MY; Gudzera OI; Gorbatiuk OB; Usenko MO; Yarmoluk SM; Tukalo MA; Volynets GP
    ACS Omega; 2021 Sep; 6(38):24910-24918. PubMed ID: 34604672
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents.
    Zhang P; Ma S
    Medchemcomm; 2019 Aug; 10(8):1329-1341. PubMed ID: 31534653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of aminoacyl-tRNA synthetases in infectious diseases and targets for therapeutic development.
    Dewan V; Reader J; Forsyth KM
    Top Curr Chem; 2014; 344():293-329. PubMed ID: 23666077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoacyl-tRNA synthetase (AARS) as an attractive drug target in neglected tropical trypanosomatid diseases-Leishmaniasis, Human African Trypanosomiasis and Chagas disease.
    Kushwaha V; Capalash N
    Mol Biochem Parasitol; 2022 Sep; 251():111510. PubMed ID: 35988745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
    De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
    Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A streamlined process for discovery and characterization of inhibitors against phenylalanyl-tRNA synthetase of Mycobacterium tuberculosis.
    Wang H; Chen S
    Methods Enzymol; 2023; 679():275-293. PubMed ID: 36682865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Proof-of-Concept of Triple-Site Inhibitors against Aminoacyl-tRNA Synthetases.
    Cai Z; Chen B; Yu Y; Guo J; Luo Z; Cheng B; Xu J; Gu Q; Zhou H
    J Med Chem; 2022 Apr; 65(7):5800-5820. PubMed ID: 35363470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided optimization and mechanistic study of a class of quinazolinone-threonine hybrids as antibacterial ThrRS inhibitors.
    Guo J; Chen B; Yu Y; Cheng B; Ju Y; Tang J; Cai Z; Gu Q; Xu J; Zhou H
    Eur J Med Chem; 2020 Dec; 207():112848. PubMed ID: 32980741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.